AXIM BIOTECHNOLOGIES, INC. (AXIM) Operating cash flow 2014–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.0MFY2023 · since FY2014: -$338,999 → -$1.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$1.0M | +49.6% |
| FY2022 | -$2.0M | +17.8% |
| FY2021 | -$2.5M | +22.7% |
| FY2020 | -$3.2M | +36.2% |
| FY2019 | -$5.0M | -4.0% |
| FY2018 | -$4.8M | -57.2% |
| FY2017 | -$3.1M | -138.1% |
| FY2016 | -$1.3M | +15.9% |
| FY2015 | -$1.5M | -354.0% |
| FY2014 | -$338,999 | — |
Source: SEC XBRL filings · For reference only · Not investment advice